Dipl.-Ing. Dr. Johanna Mader, M.Phil.
T: +43-1-4277-52321

Ries, A., Slany, A., Pirker, C., Mader, J. C., Mejri, D., Mohr, T., Schelch, K., Flehberger, D., Maach, N., Hashim, M., Hoda, M. A., Dome, B., Krupitza, G., Berger, W., Gerner, C., Holzmann, K., & Grusch, M. (2023). Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells, 12(15), [2006]. https://doi.org/10.3390/cells12152006

Meier, S. M., Kreutz, D., Winter, L., Klose, M. H. M., Cseh, K., Weiss, T., Bileck, A., Alte, B., Mader, J. C., Jana, S., Chatterjee, A., Bhattacharyya, A., Hejl, M., Jakupec, M. A., Heffeter, P., Berger, W., Hartinger, C. G., Keppler, B. K., Wiche, G., & Gerner, C. (2017). An Organoruthenium Anticancer Agent Shows Unexpected Target Selectivity For Plectin. Angewandte Chemie (International Edition), 56(28), 8267-8271. https://doi.org/10.1002/anie.201702242

In-depth proteome profiling of primary human myeloma cells: new insights into hypoxia driven metabolic, anti-apoptotic and immune evasion strategies

Astrid Slany (Speaker), Lukas Janker (Contributor), Rupert Laurenz Mayer (Contributor), Andrea Bileck (Contributor), Dominique Kreutz (Contributor), Johanna Mader (Contributor), Hermine Agis (Contributor) & Christopher Gerner (Contributor)

29 Aug 2018

Activity: Talks and presentationsTalk or oral contributionScience to Science

Aging-related proteome alterations in B cells may predispose for chronic lymphocytic leukemia

Rupert Laurenz Mayer (Speaker), Astrid Slany (Contributor), Andrea Bileck (Contributor), Johanna Mader (Contributor), Samuel Matthias Meier (Contributor), Tobias Pukrop (Contributor), Albrecht Reichle (Contributor), Josef D. Schwarzmeier (Contributor) & Christopher Gerner (Contributor)

6 Sep 2017

Activity: Talks and presentationsTalk or oral contributionScience to Science

Department of Analytical Chemistry

Währinger Straße 38
1090 Wien
Room: 1215

T: +43-1-4277-52321